Prompts winter weather advisories as cold air moves in Friday night

MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all. 

Turn Up Your Support

Pfizer is submitting data to the FDA on a COVID-19 vaccine for children ages 2 to 5. This is generally the first step in requesting emergency use authorization from the FDA for a new vaccine.

It’s very early stages, but we wanted to give you an idea of what this all means and what families might be able to expect in the next weeks and months of the pandemic. Joe Kurland, specialist in vaccines at Children’s Minnesota, broke down the research and the process for host Cathy Wurzer.

Use the audio player above to listen to the full conversation.

Subscribe to the Minnesota Now podcast on 

Health

COVID-19

Shows

Minnesota Now with Nina Moini

Host

Author

Pfizer is submitting data to the FDA on a COVID-19 vaccine for children ages 2 to 5, which is generally the first step in requesting emergency use authorization. A specialist in vaccines at Children’s Minnesota told host Cathy Wurzer what we know so far and what this could mean for families and the pandemic.

Vaccines for kids ages 2 to 5 may be on the way. Here's what we know so far.

Go Deeper.

Like this?